A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF QPI-1002 FOR PREVENTION OF DELAYED GRAFT FUNCTION IN RECIPIENTS OF A DONATION AFTER BRAIN DEATH OLDER DONOR KIDNEY TRANSPLANT (ReGIFT)
Clinical Trial Grant
Administered By
Surgery, Abdominal Transplant Surgery
Awarded By
Quark Pharmaceuticals, Inc
Start Date
April 1, 2016
End Date
July 14, 2020
Administered By
Surgery, Abdominal Transplant Surgery
Awarded By
Quark Pharmaceuticals, Inc
Start Date
April 1, 2016
End Date
July 14, 2020